5 ways biotech startups can mitigate risk to grow sustainably in the long run
TechCrunch
OCTOBER 28, 2022
In the world of biotech, for example, it’s extremely capital intensive to develop multiple products that are all going through clinical trials simultaneously. A better approach would be to focus on a lead program — a single product that they can take through various stages of development, ultimately leading to FDA approval.
Let's personalize your content